Search Results

Two anti-cancer antibodies have a much stronger effect against pediatric nerve-cell and bone cancers in mice than either one alone, researchers have discovered.

The Stanford Cancer Institute is one of 51 National Cancer Institute-designated comprehensive cancer centers, which must meet rigorous standards for improving the prevention, diagnosis and treatment of cancer.

Efforts to design a hepatitis C vaccine, understand the genetic causes of rare diseases, map genetic regulatory elements in organ systems and understand coronavirus immune responses garner over $40 million.

Stanford researcher Maria Grazia Roncarolo has been awarded $12 million by the California Institute for Regenerative Medicine for a trial aimed at improving the outcomes of stem cell transplants in children and young adults with blood cancers.

First-year graduate students in the biosciences donned lab coats provided by the Stanford Medicine Alumni Association at a ceremony marking the beginning of their studies.

The neuroscientist and pediatric neuro-oncologist is being recognized for her work to understand healthy brain development and create therapies for a group of lethal brain tumors.

The California Institute for Regenerative Medicine has awarded $31 million to three Stanford researchers to launch trials of treatments for common diseases. Four other Stanford researchers also received a total of $4.55 million.

Researchers have found that old skeletal stem cells contribute to bone fragility and poor healing in mice, but that a stem cell-boosting gel may help restore function.

Researchers have identified the mechanism of scar formation in skin and demonstrated in mice a way to make wounds heal with normal skin instead of scar tissue.

An anti-apartheid activist, humanitarian, theologian, scholar, outdoorsman and skilled woodworker, Young co-founded the Stanford Center for Biomedical Ethics.